| 1 |
33473352 | Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues. | 2021 |
1 |
| 2 |
34133540 | Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy. | 2021 |
1 |
| 3 |
28868965 | The effects of UDP-sugars, UDP and Mg2+on uridine diphosphate glucuronosyltransferase activity in human liver microsomes. | 2018 Sep |
4 |
| 4 |
32002956 | Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7. | 2018 Sep |
1 |
| 5 |
26453144 | The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolution. | 2016 Jan 1 |
1 |
| 6 |
22382330 | Identification of enzymes responsible for the N-oxidation of darexaban glucuronide, the pharmacologically active metabolite of darexaban, and the glucuronidation of darexaban N-oxides in human liver microsomes. | 2012 |
1 |
| 7 |
21859377 | In vitro and in vivo small intestinal metabolism of CYP3A and UGT substrates in preclinical animals species and humans: species differences. | 2011 Nov |
2 |
| 8 |
17998297 | Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates. | 2008 Feb |
3 |
| 9 |
15949398 | [Induction of uridine 5'-diphosphate-glucuronosyltransferase gene expression by sulforaphane and its mechanism: experimental study in human colon cancel cells]. | 2005 Mar 30 |
1 |
| 10 |
12060006 | Children versus adults: pharmacokinetic and adverse-effect differences. | 2002 |
1 |
| 11 |
10427468 | Glucuronidation in humans. Pharmacogenetic and developmental aspects. | 1999 Jun |
1 |
| 12 |
10575553 | Structural and functional studies of UDP-glucuronosyltransferases. | 1999 Nov |
1 |